Prostamax 20mg
Research-grade Prostamax 20mg. 99% purity, third-party tested with published COA.
Ships from USA
1–3 day delivery
Free Shipping
On orders $150+
Peptide Handling & Storage Guide
Storage temperature, shelf life & reconstitution (PDF)
99%+ Purity
COA included
Same-Day Shipping
Orders before 2PM EST
Secure Checkout
SSL encrypted
Shipment Protection
Lost or damaged — reshipped free
Compound Information
- Type
- Synthetic tetrapeptide bioregulator
- Molecular Formula
- C20H33N5O9
- Molecular Weight
- 487.5 g/mol
- CAS Number
- 473578-47-1
- Purity
- 99%
- Sequence
- Lys-Glu-Asp-Pro (KEDP)
Reference chemistry (free base) from public chemical databases and peer-reviewed literature. For laboratory research identification only.
Research Use Only. This vial is bound for the lab bench — supplied for in-vitro scientific work exclusively, never for administration to any person or animal.
About Prostamax
Prostamax is the four-residue peptide Lys-Glu-Asp-Pro (KEDP; PubChem CID 9848296, C20H33N5O9, ~487.5 g/mol), one of the short synthetic "peptide bioregulators" associated in the Khavinson framework with prostate tissue.
In the primary experimental report on this molecule, Prostamax was studied in rats with surgically induced chronic aseptic prostatitis; the authors reported reduced morphological signs of inflammation and, unlike the comparator agents tested, no promotion of atrophic change. This is a single-group, animal-model finding published in a non-PubMed-indexed journal and has not been independently replicated or evaluated in humans. Note that "Prostamax" is also used commercially for unrelated non-peptide products (herbal prostate supplements and other brands); this page refers only to the synthetic KEDP peptide.
Frequently Asked Questions
What is Prostamax?
Prostamax is a synthetic tetrapeptide (Lys-Glu-Asp-Pro, KEDP) in the Khavinson class of short peptide bioregulators. It is supplied strictly for in vitro and preclinical laboratory research and is not a medicine, supplement, or consumer product.
What is Prostamax peptide?
It is the four-amino-acid peptide Lys-Glu-Asp-Pro, molecular formula C20H33N5O9 (~487.5 g/mol; PubChem CID 9848296). It has been studied preclinically in a prostate-tissue model; no human efficacy or safety has been established.
What is the sequence of Prostamax?
The sequence is Lys-Glu-Asp-Pro (single-letter KEDP) — lysine, glutamic acid, aspartic acid, proline — consistent with the PubChem entry (CID 9848296).
What does research on Prostamax show?
The main published study examined Prostamax in a rat model of chronic aseptic prostatitis and reported reduced morphological signs of inflammation versus comparators. The finding is preclinical only, from a single research group, and has not been replicated or validated in humans.
Is Prostamax approved for human use?
No. The synthetic KEDP peptide sold for research is not approved by the FDA or other regulators as a drug and is not intended for human or veterinary use. Available data are limited to preclinical research.
Research & References
Independent databases and peer-reviewed literature for Prostamax. Provided for research reference only.
External resources are independent and not affiliated with or endorsed by PHIOGEN. Listed for laboratory research reference only.
